Search

Displaying results 21 - 30 of 3027 in total
  1. Drug

    Remifentanil

    go.drugbank.com/drugs/DB00899
    ApprovedInvestigational

    Remifentanil is a specific mu-type-opioid receptor agonist which means it reduces sympathetic nervous system tone, and causes respiratory depression and analgesia.

    Products: Remifentanil Kabi 1 mg Pulver zur Herstellung eines Konzentrats für eine Injektions- oder Infusionslösung, Remifentanil Kabi 2 mg Pulver zur Herstellung eines Konzentrats für eine Injektions- oder Infusionslösung
  2. Drug

    Darunavir

    go.drugbank.com/drugs/DB01264
    ApprovedInvestigational

    [A2278,A2281] It was initially approved by the FDA in 2006.

    Products: DARUNAVIR EG, DARUNAVIR HEU 400MG NET
  3. Drug

    Levonorgestrel

    go.drugbank.com/drugs/DB00367
    ApprovedInvestigational

    A subdermal implant of levonorgestrel that slowly releases the hormone over a long-term period is also available. … It was initially granted FDA approval in 1982 and was the first emergency contraceptive containing only progesterone, showing high levels of efficacy and a lack of estrogenic adverse effects when compared

    Mixtures: Aubra EQ, Aubra EQSynonyms: 13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one, 17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one
  4. Drug

    Conestat alfa

    go.drugbank.com/drugs/DB09228
    Approved

    Marketed as the product Ruconest (FDA), this drug is indicated for the treatment of acute attacks of hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency in adults.

    Products: Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung, RUCONEST 2100 U IV ENJEKSİYONLUK ÇÖZELTİ İÇİN TOZ İÇEREN FLAKON, 1 ADET
  5. Drug

    Ferric derisomaltose

    go.drugbank.com/drugs/DB15617
    ApprovedInvestigational

    Ferric derisomaltose was developed by Pharmacosmos Therapeutics ad was granted FDA approval in January 2020.

    Products: Monofer 100 mg/ml Injektions- oder Infusionslösung
  6. Drug

    Propranolol

    go.drugbank.com/drugs/DB00571
    ApprovedInvestigational

    [L6901,L6904,L6907] Propranolol was granted FDA approval on 13 November 1967.[L6904]

    Products: PROPRA RATIO 10MG FTA, PROPRA RATIO 40MG FTA
  7. Drug

    Almotriptan

    go.drugbank.com/drugs/DB00918
    Approved

    Almotriptan is a triptan drug for the treatment of migraine headaches. Almotriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels in the brain, stopping pain signals from be...

    Products: ALMOTRIPTAN EG, ALMOGRAN 12.5MG FTA
  8. Drug

    Zolpidem

    go.drugbank.com/drugs/DB00425
    ApprovedInvestigational

    Zolpidem, also known as _Ambien_, is a hypnotic drug that was initially approved by the FDA in 1992 [FDA label]. Zolpidem improves sleep in patients with insomnia. … It is available in both immediate acting and extended release forms [FDA label], [F3802].

    Products: ZOLPIDEM EG, STILNOX 10MG FTA
  9. Drug

    Eplerenone

    go.drugbank.com/drugs/DB00700
    ApprovedInvestigational

    Eplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone ...

    Products: EPLERENON HEU 25 MG NET, EPLERENON HEU 50 MG NET
  10. Drug

    Abciximab

    go.drugbank.com/drugs/DB00054
    ApprovedWithdrawn

    Abciximab is a Fab fragment of the chimeric human-murine monoclonal antibody 7E3. Abciximab binds to the glycoprotein (GP) IIb/IIIa receptor of human platelets and inhibits platelet aggregation by preventing the binding of fibrinogen, vo...

    Products: ReoPro 2 mg/ml Injektionslösung oder Infusionslösung